Publications Search Results

Your query returned 8 citations. Use the search box below to revise your search, or start a new search.

Results 1 - 8

[1]

Pub. Year

Citation

2013

Substance Abuse and Mental Health Services Administration . Emergency Department Visits among Children: Psychotherapeutic Drugs Involved in Adverse Reactions or Taken by Accident. DAWN Report. Rockville, MD: Substance Abuse and Mental Health Services Administration.

Full Text Options: PDF
Export Options: RIS/EndNote

2013

Center for Behavioral Health Statistics and Quality . Emergency Department Visits for Adverse Reactions Involving the Insomnia Medication Zolpidem. DAWN Report. Rockville, MD: Substance Abuse and Mental Health Services Administration.

Full Text Options: Original Source
Export Options: RIS/EndNote

2012

Center for Behavioral Health Statistics and Quality . Emergency Department Visits for Drug-Related Suicide Attempts among Males: 2004 to 2009. Data Spotlight. Rockville, MD: Substance Abuse and Mental Health Services Administration.

Full Text Options: PDF
Export Options: RIS/EndNote

2013

Center for Behavioral Health Statistics and Quality . Emergency Department Visits Involving Attention Deficit/Hyperactivity Disorder Stimulant Medications. DAWN Report. Rockville, MD: Substance Abuse and Mental Health Services Administration.

Full Text Options: Original Source
Export Options: RIS/EndNote

2013

Center for Behavioral Health Statistics and Quality . Emergency Department Visits Involving Buprenorphine. DAWN Report. Rockville, MD: Substance Abuse and Mental Health Services Administration.

Full Text Options: Original Source
Export Options: RIS/EndNote

2012

Wish, Eric D., Artigiani, Erin, Billing, Amy, Hauser, Wanda, Hemberg, Jordana, Shiplet, Myron, DuPont, Robert L. The emerging buprenorphine epidemic in the United States. Journal of Addictive Diseases. 31, (1), 3-7.

Full Text Options: DOI Worldcat Google Scholar
Export Options: RIS/EndNote

2010

Hertz, Sharon, Avigan, Mark . Recommendation on a Regulatory Decision for Propoxyphene-containing Products. FDA Center for Drug Evaluation and Research. Memorandum to the File NDA 10-997 Darvon (propoxyphene hydrochloride) Capsules NDA 16-862 Darvon-N (propoxyphene napsylate and acetaminophen) Tablets NDA 17-122 Darvocet-N 50 and Darvocet-N 100 (propoxyphene napsylate and acetaminophen) Tablets. 2865911, Washington, DC: United States Department of Health and Human Services.

Full Text Options: PDF
Export Options: RIS/EndNote

2013

(author unknown) . Report finds sharp rise in ED visits involving ADHD medications. Mental Health Weekly. 7-8.

Full Text Options: Worldcat Google Scholar
Export Options: RIS/EndNote